Literature DB >> 22693308

Anabolic androgenic steroid-induced cardiomyopathy, stroke and peripheral vascular disease.

Maged Y Z Youssef1, Ahmed Alqallaf, Nabila Abdella.   

Abstract

Acute stroke could be the presentation of unrecognised cardiomyopathy postanabolic androgenic steroid (AAS) abuse. A 39-year-old male patient displayed signs of acute stroke, which were associated with AAS abuse over the last 3 years. Despite the absence of symptoms and signs of congestive heart failure at presentation, AAS-induced cardiomyopathy with a thrombus in the left ventricle was discovered to be the aetiology of his stroke and peripheral vascular disease. Awareness of the complications of AAS led to the prompt treatment of the initially unrecognised dilated cardiomyopathy, and stroke.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22693308      PMCID: PMC3132623          DOI: 10.1136/bcr.12.2010.3650

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.

Authors:  H A Lane; F Grace; J C Smith; K Morris; J Cockcroft; M F Scanlon; J S Davies
Journal:  Eur J Clin Invest       Date:  2006-07       Impact factor: 4.686

2.  Acute myocardial infarction in a young man using anabolic steroids.

Authors:  Mariusz Wysoczanski; Maurice Rachko; Steven R Bergmann
Journal:  Angiology       Date:  2008-04-02       Impact factor: 3.619

3.  Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes.

Authors:  M Zaugg; N Z Jamali; E Lucchinetti; W Xu; M Alam; S A Shafiq; M A Siddiqui
Journal:  J Cell Physiol       Date:  2001-04       Impact factor: 6.384

Review 4.  Adverse effects of anabolic steroids in athletes. A constant threat.

Authors:  C Maravelias; A Dona; M Stefanidou; C Spiliopoulou
Journal:  Toxicol Lett       Date:  2005-09-15       Impact factor: 4.372

Review 5.  Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.

Authors:  Suraj Achar; Armand Rostamian; Sanjiv M Narayan
Journal:  Am J Cardiol       Date:  2010-09-15       Impact factor: 2.778

6.  Detrimental effects of anabolic steroids on human endothelial cells.

Authors:  Sandra D'Ascenzo; Danilo Millimaggi; Caterina Di Massimo; Gloria Saccani-Jotti; Francesco Botrè; Gaspare Carta; Maria Giuliana Tozzi-Ciancarelli; Antonio Pavan; Vincenza Dolo
Journal:  Toxicol Lett       Date:  2007-01-03       Impact factor: 4.372

7.  Anabolic steroid abuse and cardiac sudden death: a pathologic study.

Authors:  V Fineschi; G Baroldi; F Monciotti; L Paglicci Reattelli; E Turillazzi
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

8.  Ischemic stroke related to anabolic abuse.

Authors:  Rodrigo Daniel Santamarina; Ana Gabriela Besocke; Lucas Martin Romano; Pablo Leonardo Ioli; Sergio Eduardo Gonorazky
Journal:  Clin Neuropharmacol       Date:  2008 Mar-Apr       Impact factor: 1.592

Review 9.  Androgens and cardiovascular disease.

Authors:  Peter Y Liu; Alison K Death; David J Handelsman
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

10.  Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Authors:  F Hartgens; G Rietjens; H A Keizer; H Kuipers; B H R Wolffenbuttel
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

  10 in total
  10 in total

Review 1.  Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.

Authors:  Eberhard Nieschlag; Elena Vorona
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 2.  Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease.

Authors:  Austin C Boese; Seong C Kim; Ke-Jie Yin; Jean-Pyo Lee; Milton H Hamblin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

Review 3.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

4.  Cardiomyopathy and heart failure secondary to anabolic-androgen steroid abuse.

Authors:  Onyedika J Ilonze; Chioma O Enyi; Chibuzo C Ilonze
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-03-17

5.  Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patient.

Authors:  Reham Mohammed Shamloul; Ahmed Fathy Aborayah; Assem Hashad; Foad Abd-Allah
Journal:  BMJ Case Rep       Date:  2014-02-26

Review 6.  Androgens and stroke: good, bad or indifferent?

Authors:  Nidia Quillinan; Guiying Deng; Himmat Grewal; Paco S Herson
Journal:  Exp Neurol       Date:  2014-02-08       Impact factor: 5.330

7.  Non-ischemic Cardiomyopathy Secondary to Left Ventricular Hypertrophy due to Long-term Anabolic-androgenic Steroid Use in a Former Olympic Athlete.

Authors:  Edward T Ha; Michael L Weinrauch; Jeffrey Brensilver
Journal:  Cureus       Date:  2018-09-17

Review 8.  A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse.

Authors:  Aristides Tsatsakis; Anca Oana Docea; Daniela Calina; Konstantinos Tsarouhas; Laura-Maria Zamfira; Radu Mitrut; Javad Sharifi-Rad; Leda Kovatsi; Vasileios Siokas; Efthimios Dardiotis; Nikolaos Drakoulis; George Lazopoulos; Christina Tsitsimpikou; Panayiotis Mitsias; Monica Neagu
Journal:  J Clin Med       Date:  2019-08-23       Impact factor: 4.241

Review 9.  Treatments for people who use anabolic androgenic steroids: a scoping review.

Authors:  Geoff Bates; Marie-Claire Van Hout; Joseph Tay Wee Teck; Jim McVeigh
Journal:  Harm Reduct J       Date:  2019-12-30

Review 10.  Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.

Authors:  Marco Torrisi; Giuliana Pennisi; Ilenia Russo; Francesco Amico; Massimiliano Esposito; Aldo Liberto; Giuseppe Cocimano; Monica Salerno; Giuseppe Li Rosi; Nunzio Di Nunno; Angelo Montana
Journal:  Medicina (Kaunas)       Date:  2020-11-04       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.